Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
TABLET
**DOSAGE AND ADMINISTRATION** To be administered orally. ADULTS: Oedema : Usually, 25mg to 100mg once or twice daily or intermittently to a maximum of 200mg daily. Hypertension : 25mg to 50mg daily; either alone or in conjunction with other antihypertensive agents, to a maximum of 100mg daily. CHILDREN Usually 2.5mg per kg body weight a day, given in two doses.
ORAL
Medical Information
**INDICATIONS** **Hydrochlorzide** is indicated for the treatment of oedema and hypertension.
**CONTRAINDICATIONS** Anuria, known hypersensitivity to this product or to other sulphonamides-derived drugs.
C03AA03
hydrochlorothiazide
Manufacturer Information
APEX PHARMA MARKETING PTE. LTD.
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Active Ingredients
Documents
Package Inserts
Hydrochlorzide-50 PI.pdf
Approved: February 10, 2022